A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus.
about
Gating of long-term potentiation by nicotinic acetylcholine receptors at the cerebellum input stageDifferential effects of chronic drug treatment on alpha3* and alpha7 nicotinic receptor binding sites, in hippocampal neurones and SH-SY5Y cellsMetabolism and disposition of GTS-21, a novel drug for Alzheimer's diseaseEvaluating the role of the alpha-7 nicotinic acetylcholine receptor in the pathophysiology and treatment of schizophrenia.Smoking, Genetics and Schizophrenia: Evidence for Self Medication.Paired-pulse potentiation of alpha7-containing nAChRs in rat hippocampal CA1 stratum radiatum interneurones.High throughput electrophysiology with Xenopus oocytesCompromised neuroplasticity in cigarette smokers under nicotine withdrawal is restituted by the nicotinic α4β2-receptor partial agonist varenicline.Activation of presynaptic alpha7 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurones in anaesthetized rats: an in vivo iontophoretic studySSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile.Allosteric modulation of related ligand-gated ion channels synergistically induces long-term potentiation in the hippocampus and enhances cognition.Naturally-expressed nicotinic acetylcholine receptor subtypes.Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice.An autoradiographic analysis of rat brain nicotinic receptor plasticity following dietary choline modification.The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus.Nicotinic ACh receptors in the hippocampus: role in excitability and plasticity.Nicotinic receptors in neurodegeneration.CHRNA7 Polymorphisms and Dementia Risk: Interactions with Apolipoprotein ε4 and Cigarette Smoking.Nicotinic receptors containing the alpha7 subunit: a model for rational drug design.Neurotransmitter receptor and time dependence of the synaptic plasticity disrupting actions of Alzheimer's disease Aβ in vivo.Characterization of a nicotine-sensitive neuronal population in rat entorhinal cortex.Alpha7 neuronal nicotinic receptors as a drug target in schizophrenia.Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.Ca2+ permeability of nicotinic acetylcholine receptors in rat hippocampal CA1 interneurones.Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors.Neurotoxicity of channel mutations in heterologously expressed alpha7-nicotinic acetylcholine receptors.Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo.The Nemertine Toxin Anabaseine and Its Derivative DMXBA (GTS-21): Chemical and Pharmacological Properties.Dendritic Ca2+ signalling due to activation of alpha 7-containing nicotinic acetylcholine receptors in rat hippocampal neurons.Synaptic transmission at nicotinic acetylcholine receptors in rat hippocampal organotypic cultures and slices.Choline-mediated depression of hippocampal synaptic transmission.Simvastatin Enhances Spatial Memory and Long-Term Potentiation in Hippocampal CA1 via Upregulation of α7 Nicotinic Acetylcholine Receptor.Use of behavioural and long-term potentiation models in the development of memory-improving drugs.Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus.
P2860
Q21133509-EB7E3F55-1D41-4D4D-A12A-1E140E5DBC1AQ28345770-7447C93C-9B8D-4E24-8269-3957CB982EC1Q28371375-5A1ECA2D-8DA8-4711-BC5C-9F45BAC24678Q30428422-041C372A-B72D-492F-8858-65794ACC314BQ30491841-46C24B82-F1B7-415D-AB31-2310F7CF9847Q33222788-4934FC24-B94A-43D0-9642-DBF636C28E10Q33400496-CE5590C7-448D-4F9A-9E0D-C6BEDFC06A56Q33684431-D43BB3ED-23D7-43CB-851C-583F43159310Q33685905-368B1798-D6BD-4171-8CF4-20614C84F748Q34571365-7C0ED85E-3BA4-47F9-B4FE-66A3B295F324Q34702234-4C30674D-4681-4B98-8F2D-4BD8EDADB052Q35185264-4829DCDC-515C-49AC-806F-DE9D22A97AACQ35946508-DA2CF87B-1753-4520-A5A0-5380447C4DC7Q35990855-A5C40BE4-B4B9-4CDB-8C48-D88EBAF1EEBCQ36144877-0DC625DB-885D-4083-AB40-46B5461EDF0FQ36349953-A0D91513-69DA-43C0-A2BC-BFF20BA8863AQ36828916-8E85386F-9BB6-4531-8CBC-8E3EBF025BE3Q36959844-DB54AF92-6332-4815-B157-F65B11FD26C8Q37347201-0224C62B-D0D3-4148-A704-66592A692BD3Q37350693-CB1B19CA-6653-492A-8822-FFEBFAAEF971Q37396117-03F05779-156C-44E2-B4D9-1885C173E1FEQ38066550-C6924391-A01E-4C8D-BB16-81537A0FFD47Q38068415-0FB901D2-E28B-4ADF-A15F-35E8D16A8A50Q40414029-17C5569C-CC54-4DEA-999F-FF9A1D9EA151Q40444570-1E747A30-07DF-4ABB-93B3-40F5DF2222F9Q40799594-1AA52E77-A431-4730-9910-9228C38FA50CQ44336667-2424F14C-69E1-4DC7-B947-E27B6B90FEF7Q46776125-3F335D22-DA9A-425D-BDCB-A109DEDFE724Q48164149-C12A67B7-537A-494F-9FB1-01EAF522D657Q48269976-CF84FA3A-1918-494C-B99B-466B0709CB54Q48832603-0764040E-A988-4FF3-BD7E-3A0A0D61B7A2Q50576727-507A9127-8F85-4896-B1A4-6E135E736C47Q51962312-C738B7C0-269B-4653-BDD6-8236EEFD44FEQ52023930-8CF16ED4-3335-42F0-980A-F351709458A9
P2860
A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh
1994年學術文章
@zh-hant
name
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@en
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@nl
type
label
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@en
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@nl
prefLabel
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@en
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@nl
P2093
P1433
P1476
A novel nicotinic agonist faci ...... iation in the rat hippocampus.
@en
P2093
P304
P356
10.1016/0304-3940(94)90433-2
P407
P577
1994-02-01T00:00:00Z